CTT Pharmaceutical Holdings Inc (CTTH)
OTHER OTC:CTTH
Total Valuation
CTT Pharmaceutical Holdings has a market cap or net worth of $4.00M. The enterprise value is $1.49M.
Market Cap$4.00M
Enterprise Value$1.49M
Share Statistics
CTT Pharmaceutical Holdings has 58,712,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,712,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CTT Pharmaceutical Holdings’s return on equity (ROE) is -2.83 and return on invested capital (ROIC) is -171.42%.
Return on Equity (ROE)-2.83
Return on Assets (ROA)-1.81
Return on Invested Capital (ROIC)-171.42%
Return on Capital Employed (ROCE)-2.30
Revenue Per Employee0.00
Profits Per Employee-77.95K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CTT Pharmaceutical Holdings is ―. CTT Pharmaceutical Holdings’s PEG ratio is 0.72.
PE Ratio―
PS Ratio0.00
PB Ratio62.73
Price to Fair Value62.73
Price to FCF-45.85
Price to Operating Cash Flow-53.62
PEG Ratio0.72
Income Statement
In the last 12 months, CTT Pharmaceutical Holdings had revenue of 0.00 and earned -155.91K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-6.43K
Operating Income-126.77K
Pretax Income-155.91K
Net Income-155.91K
EBITDA-120.34K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -75.47K and capital expenditures 0.00, giving a free cash flow of -75.47K billion.
Operating Cash Flow-75.47K
Free Cash Flow-75.47K
Free Cash Flow per Share>-0.01
Dividends & Yields
CTT Pharmaceutical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.70
52-Week Price Change15.00%
50-Day Moving Average0.08
200-Day Moving Average0.06
Relative Strength Index (RSI)50.01
Average Volume (3m)66.33K
Important Dates
CTT Pharmaceutical Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CTT Pharmaceutical Holdings as a current ratio of 0.50, with Debt / Equity ratio of 34.11%
Current Ratio0.50
Quick Ratio0.50
Debt to Market Cap<0.01
Net Debt to EBITDA-0.03
Interest Coverage Ratio-63.26
Taxes
In the past 12 months, CTT Pharmaceutical Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CTT Pharmaceutical Holdings EV to EBITDA ratio is -28.78, with an EV/FCF ratio of -45.90.
EV to Sales0.00
EV to EBITDA-28.78
EV to Free Cash Flow-45.90
EV to Operating Cash Flow-45.90
Balance Sheet
CTT Pharmaceutical Holdings has $15.36K in cash and marketable securities with $18.81K in debt, giving a net cash position of -$3.46K billion.
Cash & Marketable Securities$15.36K
Total Debt$18.81K
Net Cash-$3.46K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CTT Pharmaceutical Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―